Conversations on Cancer- LBGTQ plus OCE: A Voice in Clinical Trials
June 23, 2020
- June 23, 2020
- Organized By:
Dr. Richard Pazdur is the director of the FDA's Oncology Center of Excellence (OCE).
Kellan Baker is the Centennial Scholar and a Robert Wood Johnson Health Policy Research Scholar in the Department of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health.
D Magrini is the Assistant Director of Community Commitment, Whiteman-Walker Health (WWH) and cancer survivor.
Joshua Riley is a licensed professional counselor (LPC) and serves as Director of Community Commitment at Whitman-Walker Health.
NFN Scout is the Deputy Director of the National LGBT Cancer Network and the principal investigator of the CDC-funded LGBTQ tobacco-related cancer disparity network.
Dr. Karen Winkfield is a Radiation Oncologist specializing in the management of cancers of the breast and blood who has written several articles and book chapters focused on treatment-related toxicities in cancer survivorship.
Rea Blakey, Associate Director of External Outreach and Engagement, Oncology Center of Excellence, FDA
Dr. Jamie Brewer is a medical oncologist and clinical reviewer on the Genitourinary Cancer team in the Office of Oncologic Diseases (OOD)
Conversations on Cancer - Making Cancer Personal at the FDA” is an educational lecture series for FDA staff. Please join the OCE Conversations on Cancer titled “LGBTQ + OCE= A Voice in Clinical Trials and Cancer Drug Development” on Tuesday, June 23rd at 1:00 pm (EDT) through WebEx. The one-hour conversation will include topics such as barriers for inclusion in clinical trials and bridging knowledge gaps for specific types of cancers in this vulnerable population.
FDA provided a free-of-charge, live webcast of this workshop.
For additional information, please send an email to: OCE-Engagement@fda.hhs.gov